BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36396062)

  • 21. Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC.
    Ganesh A; Korpics M; Pasquinelli M; Feldman L; Spiotto M; Koshy M
    Clin Lung Cancer; 2023 Jan; 24(1):60-71. PubMed ID: 36289032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Jiao Z; Li H; Xiao Y; Aggarwal C; Galperin-Aizenberg M; Pryma D; Simone CB; Feigenberg SJ; Kao GD; Fan Y
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1647-1656. PubMed ID: 33333202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Cerra-Franco A; Liu S; Azar M; Shiue K; Freije S; Hinton J; Deig CR; Edwards D; Estabrook NC; Ellsworth SG; Huang K; Diab K; Langer MP; Zellars R; Kong FM; Wan J; Lautenschlaeger T
    Clin Lung Cancer; 2019 May; 20(3):186-193.e3. PubMed ID: 30711394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
    Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
    Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognositc significance of SUV
    Dong M; Liu J; Sun X; Xing L
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer.
    Lalonde R; Abdelhakiem M; Keller A; Huq MS
    Radiother Oncol; 2022 Apr; 169():90-95. PubMed ID: 35202740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).
    Lucas JT; Kuremsky JG; Soike M; Hinson WW; Kearns WT; Hampton CJ; Blackstock AW; Urbanic J
    Lung Cancer; 2014 Jul; 85(1):59-65. PubMed ID: 24813936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel nomograms to predict lymph node metastasis and distant metastasis in resected patients with early-stage non-small cell lung cancer.
    Tian Y; He Y; Li X; Liu X
    Ann Palliat Med; 2021 Mar; 10(3):2548-2566. PubMed ID: 33691451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
    Prabhu RS; Press RH; Boselli DM; Miller KR; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Patel KR; Asher AL; Sumrall AL; Curran WJ; Shu HG; Burri SH
    J Neurooncol; 2018 Mar; 137(1):147-154. PubMed ID: 29218431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
    Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
    Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer.
    Amin SA; Alam M; Baine MJ; Meza JL; Bennion NR; Zhang C; Rahman I; Lin C
    Radiother Oncol; 2021 Feb; 155():254-260. PubMed ID: 33317997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
    Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
    Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
    Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
    J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
    Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
    Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC).
    Zhu X; Hou R; Li X; Jiang C; Xia W; Fu X
    Radiat Oncol; 2020 Feb; 15(1):43. PubMed ID: 32070383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?
    Klement RJ; Belderbos J; Grills I; Werner-Wasik M; Hope A; Giuliani M; Ye H; Sonke JJ; Peulen H; Guckenberger M
    J Thorac Oncol; 2016 Jul; 11(7):1132-9. PubMed ID: 27060654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
    Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
    Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.